CoChat

Iron Supplementation for the Treatment of Chronic Heart Failure and Iron Deficiency: Systematic Review and Meta-Analysis

Avni, Tomer, Leibovici, Leonard, Gafter-Gvili, Anat · 2012 · European Journal of Heart Failure
Cited by 125

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Aims: Over half of chronic heart failure (CHF) patients are anaemic, and iron deficiency is common. Iron replacement therapy (oral or i.v.) might improve exercise capacity and quality of life (QOL). Methods and results: We carried out a systematic review and meta-analysis of all randomized control trials that compared iron with no therapy for CHF patients with iron deficiency, whether or not they were anaemic. We searched electronic databases as well as haematology and cardiology conferences up to August 2011. The primary outcome was the effect of iron on QOL parameters such as New York Heart Association (NYHA) class and the Minnesota Living With Heart Failure Questionnaire (MLHWFQ). Secondary outcomes included all-cause mortality, mean ejection fraction, 6 min walk distance (6MWD), hospitalizations due to any cause, iron indices, C-reactive protein levels, and adverse events. Four trials performed fulfilled the inclusion criteria. A total of 370 patients were treated with i.v. iron, compared with 224 control patients. There was significant improvement in QOL in the iron arm according to the MLWHFQ score at 26 weeks, with a weighted mean difference of –18.00 (–22.54, –13.46, I2 = 0%]. The point estimate for improvement in NYHA class was in favour of iron. Iron reduced the number of hospitalizations and C-reactive protein levels, and increased the 6MWD and mean ejection fraction. Iron indices were significantly improved without a change in haemoglobin levels. No increase in the rate of adverse events was found. Conclusion: Intravenous iron therapy is associated with improved QOL parameters, reduction in hospitalizations, and increased 6MWD. Treatment with i.v. iron is safe, with no increased rate of adverse events. The results of our analysis are limited by the paucity of trials, and significant heterogeneity between trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurjhf/hfs017

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 125

Metadata

Authors
Avni, T., Leibovici, L., & Gafter-Gvili, A.
Venue
European Journal of Heart Failure
Published
2012-04-01
Volume
14
Issue
4
Pages
423-429
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2043010327
Cited by
125
References
10
FWCI
1.49
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Iron Supplementation for the Treatment of Chronic Heart Failure and Iron Deficiency: Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1093/eurjhf/hfs017
The paper
Avni, T., Leibovici, L., & Gafter-Gvili, A. (2012). Iron Supplementation for the Treatment of Chronic Heart Failure and Iron Deficiency: Systematic Review and Meta-Analysis. European Journal of Heart Failure. https://doi.org/10.1093/eurjhf/hfs017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.